Targeted protein degradation as therapies
Interviewee/Contributor
Peter Charlish
Organisation
MedNous
Research Directory
MiNA Therapeutics pioneers small activating RNA
Interviewee/ContributorRobert HabibOrganisationMiNA Therapeutics LtdQ3 2021 Stock Market Performance
Interviewee/ContributorVictoria EnglishOrganisationMedNousCheckpoint Inhibitors: A decade of innovation
Interviewee/ContributorBruno PagliaraOrganisationMedNousESMO 2021: Oncology developers present their findings
Interviewee/ContributorVictoria English and Bruno PagliaraOrganisationMedNousWHO panel advises on governance of genome editing
Interviewee/ContributorVictoria EnglishOrganisationMedNousVectorY Therapeutics targets misfolded proteins
Interviewee/ContributorAlexander Vos and Sander van DeventerOrganisationVectorY Therapeutics BVHow faster insulin can enable the artificial pancreas
Interviewee/ContributorDavid GerringOrganisationArecor Therapeutics PlcRevisiting herpes simplex virus leads to invention
Interviewee/ContributorGerald KleymannOrganisationInnovative Molecules GmbHShining a light on the dark genome
Interviewee/ContributorDanuta Jeziorska